wuhan-umbria.com
savouring life - merging experiences
Category parkinson
Knowledge clustering PD and PE
This is the first step in our project to analyze a significant chunk of literatur regarding Parkinson disease and Physical exercise (PD and PE) Study Semantic Clustering of Parkinson’s Disease Literature This project implements an automated pipeline to extract, analyze,…
Parkinson’s disease (PD) and Physical exercise (PE)
Study Aim This study aims to provide a comprehensive overview of the relationship between Parkinson’s disease and physical exercise. The key research questions are: In addition, I seek to explore: Definition of the Corpus To define a literature corpus for…
The role of alfa synuclein inParkinson’s disease
I have been diagnosed in 2020 with Parkinson’s disease. My background is a MSC in Biochemistry and a PhD in Biology. After 10 years in the lab I spent most of my life on data presentation and recovery in the…
FAM171A2: Urgent need for research
Science Magazine, February 21, 2025, published a paper by Kai-Min Wu and others titled “Neuronal FAM171A2 mediates α-synuclein fibril uptake and drives Parkinson’s disease.” This study proposed that FAM171A2 is a key player in the development of Parkinson’s disease (PD),…
For the admission of test Pioneers in Drug development
The typical timeframe between the discovery of a substance with potential therapeutic effects and its approval as a registered medicine is about 10–15 years. This lengthy process is often attributed not only to technical hurdles but also to the social…
Anle138b: More Research and Acceleration of Clinical Testing is Needed
(written with ChatGPT40, version April 2025) 1. History 1.1 Origin in Prion Research Anle138b was originally developed in the context of prion diseases, such as scrapie, due to its ability to disrupt the formation of pathogenic protein aggregates. Prion pathologies share…